High-risk HPV-positive and-negative high-grade cervical dysplasia: Analysis of 5-year outcomes

被引：41

作者：

Bogani, Giorgio ^{[1
]}

Sopracordevole, Francesco ^{[2
]}

Di Donato, Violante ^{[3
]}

Ciavattini, Andrea ^{[4
]}

Ghelardi, Alessandro ^{[5
]}

Lopez, Salvatore ^{[1
]}

Simoncini, Tommaso ^{[6
]}

Plotti, Francesco ^{[7
]}

Casarin, Jvan ^{[8
]}

Serati, Maurizio ^{[8
]}

Pinelli, Ciro ^{[9
]}

Valenti, Gaetano ^{[3
]}

Bergamini, Alice ^{[10
]}

Gardella, Barbara ^{[11
]}

Dell'acqua, Andrea ^{[12
]}

Monti, Ermelinda ^{[12
]}

Vercellini, Paolo ^{[12
]}

Fischetti, Margherita ^{[3
]}

D'ippolito, Giovanni ^{[13
]}

Aguzzoli, Lorenzo ^{[13
]}

Mandato, Vincenzo D. ^{[13
]}

Carunchio, Paola ^{[13
]}

Carlinfante, Gabriele ^{[13
]}

Giannella, Luca ^{[4
]}

Scaffa, Cono ^{[14
]}

Falcone, Francesca ^{[14
]}

Borghi, Chiara ^{[15
]}

Ditto, Antonino ^{[1
]}

Malzoni, Mario ^{[16
]}

Giannini, Andrea ^{[17
]}

Salerno, Maria Giovanna ^{[17
]}

Liberale, Viola ^{[18
]}

Contino, Biagio ^{[18
]}

Donfrancesco, Cristina ^{[19
]}

Desiato, Michele ^{[19
]}

Perrone, Anna Myriam ^{[20
]}

Dondi, Giulia ^{[20
]}

De Iaco, Pierandrea ^{[20
]}

Chiappa, Valentina ^{[1
]}

Ferrero, Simone ^{[21
,22
]}

Sarpietro, Giuseppe ^{[23
]}

Matarazzo, Maria G. ^{[23
]}

Cianci, Antonio ^{[23
]}

Bosio, Sara ^{[24
]}

Ruisi, Simona ^{[24
]}

Guerrisi, Rocco ^{[9
]}

Brusadelli, Claudia ^{[9
]}

Mosca, Lavinia ^{[25
]}

Lagana, Antonio Simone ^{[8
]}

Tinelli, Raffaele ^{[26
]}

机构：

[1] Fdn IRCCS Ist Nazl Tumori Milano, Gynecol Oncol Unit, Milan, Italy

[2] Natl Canc Inst, Ctr Riferimento Oncol, Gynecol Oncol Unit, Via F Gallini 2, I-33081 Aviano, Italy

[3] Sapienza Univ Rome, Dept Gynecol Obstet & Urol Sci, Rome, Italy

[4] Polytech Univ Marche, Gynecol Sect, Womans Hlth Sci Dept, Ancona, Italy

[5] Osped Apuane, Azienda Usl Toscana Nord Ovest, UOC Ostetricia & Ginecol, Massa, Italy

[6] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy

[7] Campus Biomed Univ Rome, Rome, Italy

[8] Univ Insubria, Filippo Del Ponte Hosp, Dept Obstet & Gynecol, Varese, Italy

[9] Osped Circolo Fdn Macchi, Varese, Italy

[10] IRCCS Osped San Raffaele, Dept Obstet & Gynecol, Milan, Italy

[11] Univ Pavia, IRCCS S Matteo Fdn, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy

[12] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gynaecol Unit, Milan, Italy

[13] Azienda Unita Sanit Locale IRCCS Reggio Emilia, Cesare Magati Hosp, Div Obstet & Gynecol, Scandiano, Italy

[14] IRCCS Fdn G Pascale, Ist Nazl Tumori, Gynecol Oncol Unit, Naples, Italy

[15] S Anna Univ Hosp, Dept Obstet & Gynecol, Ferrara, Italy

[16] Ctr Adv Endoscop Gynecol Surg, Endoscop Malzoni, Avellino, Italy

[17] San Camillo Forlanini Hosp, Dept Womans & Childs Hlth, Obstet & Gynecol Unit, Rome, Italy

[18] Osped Maria Vittoria, Dept Obstet & Gynecol, Turin, Italy

[19] Osped S Trinita Sora, Dept Obstet & Gynecol, Azienda ASL Frosinone, Sora, Italy

[20] St Orsola Malpighi Hosp, Gynecol Oncol Unit, I-40138 Bologna, Italy

[21] IRCCS Osped Policlin San Martino, Acad Unit Obstet & Gynecol, Genoa, Italy

[22] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy

[23] Univ Catania, Gynecol Clin, Dept Gen Surg & Med Surg Specialties, Via S Sofia 78, I-95124 Catania, Italy

[24] Univ Milan, San Paolo Hosp, I-20142 Milan, Italy

[25] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, I-80138 Naples, Italy

[26] Valle Itria Hosp, Dept Obstet & Gynecol, Via San Francesco da Paola, I-74015 Taranto, Italy

[27] Fdn Policlin Univ A Gemelli, IRCCS, Dipartimento Salute Donna & Bambino & Salute Pubb, UOC Ginecol Oncol, Rome, Italy

[28] Univ Sassari, Gynecol & Obstet Unit, Dept Med Surg & Expt Sci, Sassari, Italy

[29] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Sch Med, Naples, Italy

来源：

GYNECOLOGIC ONCOLOGY | 2021年 / 161卷 / 01期

关键词：

HPV; Negative; Positive; CIN; Conization; CANCER; NEOPLASIA; SUBTYPES; WOMEN;

D O I：

10.1016/j.ygyno.2021.01.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objective. To evaluate the outcomes of high-risk (HR) HPV-positive and-negative women affected by high-grade cervical dysplasia. Methods. This is a retrospective multi-institutional study. Medical records of consecutive patients with high-grade cervical dysplasia undergoing conization between 2010 and 2014 were retrieved. All patients included had at least 5 years of follow-up. A propensity-score matching was adopted in order to reduce the presence of con-founding factors between groups. Kaplan-Meir and Cox hazard models were used to estimate 5-year outcomes. Results. Overall, data of 2966 women, affected by high-grade cervical dysplasia were reviewed. The study population included 1478 (85%) and 260 (15%) women affected by HR-HPV-positive and HR-HPV-negative high-grade cervical dysplasia. The prevalence of CIN2 and CIN3 among the HR-HPV-positive and-negative cohort was similar (p = 0.315). Patients with HR-HPV-positive high-grade cervical dysplasia were at higher risk of 5-year recurrence (after primary conization) that HR-HPV-negative patients (p < 0.001, log-rank test). Via multi-variate analysis, HR-HPV-negative women were at low risk of recurrence (HR: 1.69 (95%CI: 1.05, 4.80); p = 0.018, Cox Hazard model). A propensity-score matched comparison was carried out in order to reduce biases that are related to the retrospective study design. In comparison to HR-HPV-negative patients, thosewith HR-HPV-positive CIN3 was associate with a 8-fold increase in the risk of recurrence (p < 0.001, log-rank test). Conclusions. HR-HPV-negative high-grade cervical dysplasia is not uncommon, accounting for 15% of our study population. Those patients experience more favorable outcomes than patients with documented HR-HPV infection(s). Further prospective studies are needed to corroborate our data. (c) 2021 Elsevier Inc. All rights reserved.

引用

页码：173 / 178

页数：6

共 50 条

[1] Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening
Stephanie M. Peace
Ashley J. Jennings
Archives of Gynecology and Obstetrics, 2022, 305 : 87 - 93
[2] Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening
Peace, Stephanie M.
Jennings, Ashley J.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (01) : 87 - 93
[3] Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
Giannini, Andrea
Di Donato, Violante
Sopracordevole, Francesco
Ciavattini, Andrea
Ghelardi, Alessandro
Vizza, Enrico
D'Oria, Ottavia
Simoncini, Tommaso
Plotti, Francesco
Casarin, Jvan
D'Auge, Tullio Golia
Cuccu, Ilaria
Serati, Maurizio
Pinelli, Ciro
Bergamini, Alice
Gardella, Barbara
Dell'Acqua, Andrea
Monti, Ermelinda
Vercellini, Paolo
D'Ippolito, Giovanni
Aguzzoli, Lorenzo
Mandato, Vincenzo Dario
Giannella, Luca
Scaffa, Cono
Ditto, Antonino
Falcone, Francesca
Borghi, Chiara
Malzoni, Mario
Di Giovanni, Alessandra
Salerno, Maria Giovanna
Liberale, Viola
Contino, Biagio
Donfrancesco, Cristina
Desiato, Michele
Perrone, Anna Myriam
De Iaco, Pierandrea
Ferrero, Simone
Sarpietro, Giuseppe
Matarazzo, Maria G.
Cianci, Antonio
Cianci, Stefano
Bosio, Sara
Ruisi, Simona
Mosca, Lavinia
Tinelli, Raffaele
De Vincenzo, Rosa
Zannoni, Gian Franco
Ferrandina, Gabriella
Petrillo, Marco
Capobianco, Giampiero
VACCINES, 2023, 11 (03)
[4] miRNA expression analysis in high-risk HPV-positive cervical scrapes for the detection of cervical disease
Gonzalez Ramirez, Martha Isabel
Agudelo, Samuel
Cecilia Agudelo, Maria
Garai, Jone
Li, Li
Orozco Castano, Carlos Alberto
Zabaleta, Jovanny
Sanchez Vasquez, Gloria Ines
CANCER RESEARCH, 2022, 82 (12)
[5] High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women With Low-Grade Cervical Cytology
Daily, Laura R.
Erickson, Britt K.
Pasko, Daniel N.
Straughn, J. Michael
Huh, Warner K.
Leath, Charles A., III
JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (03) : 207 - 211
[6] Prevalence of high-grade cervical intraepithelial neoplasia in women with persistent high-risk HPV genotypes and negative cytology
Macdonald, M.
Crossley, J.
Ellis, K.
Dudding, N.
Lyon, R.
Smith, J. H. F.
Tidy, J. A.
Palmer, J. E.
CYTOPATHOLOGY, 2018, 29 (02) : 133 - 142
[7] Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions
El-Zein, Mariam
Bouten, Sheila
Abdrabo, Lina Sobhi
Siblini, Aya
Louvanto, Karolina
Franco, Eduardo
Ferenczy, Alex
JOURNAL OF LOWER GENITAL TRACT DISEASE, 2023, 27 (01) : 12 - 18
[8] Five-Year Risks of CIN 3+and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results
Katki, Hormuzd A.
Schiffman, Mark
Castle, Philip E.
Fetterman, Barbara
Poitras, Nancy E.
Lorey, Thomas
Cheung, Li C.
Raine-Bennett, Tina
Gage, Julia C.
Kinney, Walter K.
JOURNAL OF LOWER GENITAL TRACT DISEASE, 2013, 17 : S50 - S55
[9] Management of high-risk HPV-positive women for detection of cervical (pre)cancer
Luttmer, Roosmarijn
De Strooper, Lise M. A.
Steenbergen, Renske D. M.
Berkhof, Johannes
Snijders, Peter J. F.
Heideman, Danielle A. M.
Meijer, Chris J. L. M.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (09) : 961 - 974
[10] Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more
Siebers, A. G.
van der Linden, H.
Vedder, J. E. M.
Bekkers, R. L. M.
Melchers, W. L. G.
Bulten, J.
CYTOPATHOLOGY, 2018, 29 (03) : 275 - 280

← 1 2 3 4 5 →